Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
filingDate |
2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f64f5ee30a58d6524377738af116c20a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30469fe1a37cf014a961b1c59f56d16b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db527101146fe57aec03227e77c60a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c53ea8dea205dd3b100ac93ef0a3dae5 |
publicationDate |
2007-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1827416-A1 |
titleOfInvention |
Pharmaceutical compositions |
abstract |
The present invention relates to a pharmaceutical composition comprising primarily amorphous 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, 1-methylethyl ester. |
priorityDate |
2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |